Inventor

Dana K. Winter

Inventor

Rigaud, CA

Overview

8→

Patents

2018–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 8 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%

C07DHeterocyclic compounds36%

A61KPreparations for medical, dental or toiletry purposes18%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium9%

PatentTitleYear

11,040,957Heteroaromatic compounds useful for the treatment of proliferative diseases2021 10,906,889Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)2021 10,865,206Inhibitors of cyclin-dependent kinase 7 (CDK7)2020 10,519,135Inhibitors of cyclin-dependent kinase 7 (CDK7)2019 10,308,648Inhibitors of cyclin-dependent kinase 7 (CDK7)2019 10,106,526Inhibitors of cyclin-dependent kinase 7 (CDK7)2018 10,059,690Inhibitors of cyclin-dependent kinase 7 (CDK7)2018 10,047,070Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)2018

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2018–2021Patents assigned to SYROS PHARMACEUTICALS INC (6)· patent assignee history

2018–2021Patents assigned to DANA FARBER CANCER INST INC (3)· patent assignee history

2018–2021Based in Rigaud, CA· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
SYROS PHARMACEUTICALS INC	6	2018–2021
DANA FARBER CANCER INST INC	3	2018–2021

Locations

Location	Patents	Span
Rigaud, CA	8	2018–2021